









Markets
/
Stocks
/
nasdaq-irix
/

IRIDEX Corp

IRIX

1.460USD

+0.030+2.10%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

24.89MMarket Cap

LossP/E TTM



IRIDEX Corp

1.460

+0.030+2.10%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of IRIDEX Corp

Currency: USD Updated: 2026-02-06

Key Insights

IRIDEX Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 95 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

IRIDEX Corp's Score

Industry at a Glance

Industry Ranking

95 / 205

Overall Ranking

247 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

IRIDEX Corp Highlights

StrengthsRisks

IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Growing

The company is in a growing phase, with the latest annual income totaling USD 48.67M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 48.67M.

Undervalued

The company’s latest PE is -4.85, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 3.14M shares, increasing 6.56% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 389.06K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.39.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

3.000

Target Price

+109.79%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of IRIDEX Corp is 6.19, ranking 166 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 12.48M, representing a year-over-year increase of 7.80%, while its net profit experienced a year-over-year increase of 18.62%.

Score

Industry at a Glance

Previous score

6.19

Change



Financials

6.54

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.25

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

5.91

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.19

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.09

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

IRIDEX Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of IRIDEX Corp is 8.37, ranking 26 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -4.85, which is -69.92% below the recent high of -1.46 and -40.30% above the recent low of -6.80.

Score

Industry at a Glance

Previous score

8.37

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 95/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of IRIDEX Corp is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

3.000

Target Price

+109.79%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

IRIDEX Corp

IRIX

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of IRIDEX Corp is 7.22, ranking 42 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.69 and the support level at 1.18, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.15

Change

0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.040

Neutral

RSI(14)

58.015

Neutral

STOCH(KDJ)(9,3,3)

35.191

Neutral

ATR(14)

0.119

High Vlolatility

CCI(14)

-56.417

Neutral

Williams %R

65.290

Sell

TRIX(12,20)

0.993

Sell

StochRSI(14)

38.506

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

1.449

Buy

MA10

1.480

Sell

MA20

1.447

Buy

MA50

1.199

Buy

MA100

1.139

Buy

MA200

1.140

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of IRIDEX Corp is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 18.28%, representing a quarter-over-quarter increase of 18.81%. The largest institutional shareholder is The Vanguard, holding a total of 578.71K shares, representing 3.37% of shares outstanding, with 4.97% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Topcon Corp

1.62M

+0.37%

Stanley Manne Trust

1.07M

Paragon JV Partners, LLC

1.00M

The Vanguard Group, Inc.

Star Investors

578.71K

-1.21%

Roland (Brent Alexander)

461.71K

Moore (William M)

402.00K

+14.86%

Renaissance Technologies LLC

Star Investors

389.06K

+2.72%

Roland Family Support Trust

223.69K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of IRIDEX Corp is 2.98, ranking 135 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.68. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.